Tehran University of Medical Sciences

Science Communicator Platform

Share By
Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review Pubmed



Mohammadi Z1, 2 ; Poustchi H1, 2 ; Motamedgorji N2 ; Eghtesad S2 ; Hekmatdoost A3 ; Saniee P4 ; Merat S1, 2
Authors

Source: Archives of Iranian Medicine Published:2020


Abstract

Background: With the increasing prevalence of obesity, non-alcoholic fatty liver disease (NAFLD), has become a frequent cause of chronic liver disease, often leading to cirrhosis. In recent decades, gut microbiota have been evaluated as an effective factor in NAFLD pathogenesis, causing steatohepatitis by involving the host immune system. The aim of this study is to evaluate gut microbiota dysbiosis in NAFLD/NASH patients in comparison to healthy controls. Methods: We conducted a systematic search of published studies that have examined the composition of gut microbiota in relation to NAFLD. PubMed, Scopus and ISI Web of Science were searched. After the exclusion of irrelevant studies, 15 eligible studies were included and summarized. Results: Overall, some studies reported the composition of microbiota at the phyla level, while others reported them at smaller subgroups; the results of studies were contradictory in some cases. Conclusion: Overall, study findings indicate a relationship between microbial composition and NAFLD. Study methods and sequencing techniques influenced these results. © 2020 The Author(s).
Other Related Docs
8. Gut Microbiota and Covid-19: A Systematic Review, Health Science Reports (2023)
10. Non-Alcoholic Fatty Liver Diseases: From Role of Gut Microbiota to Microbial-Based Therapies, European Journal of Clinical Microbiology and Infectious Diseases (2020)
17. Linking Diet and Gut Microbiota in Multiple Sclerosis, Diet and Nutrition in Neurological Disorders (2023)